Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

Fair Value

Margin Of Safety %

Put/Call OI Ratio

0.11

Float Short​ %​

1.63

EPS 1 Diff

0.42

EPS Year Diff

0.37

Ticker: PRPH




21 items of 1

DateSymbolLastP/C OIP/C VolTotal OI
2024-09-06PRPH2.90.191.00706
2024-09-09PRPH2.740.200.00710
2024-09-10PRPH2.770.19999.99742
2024-09-11PRPH2.640.190.00743
2024-09-12PRPH2.560.180.00768
2024-09-13PRPH2.50.180.00769
2024-09-16PRPH2.460.180.00771
2024-09-17PRPH2.610.180.00773
2024-09-18PRPH2.560.180.00773
2024-09-19PRPH2.510.180.00773
2024-09-20PRPH2.310.130.78739
2024-09-23PRPH2.40.140.02723
2024-09-24PRPH2.210.130.00774
2024-09-25PRPH2.150.130.00794
2024-09-26PRPH2.290.120.09825
2024-09-27PRPH2.40.120.03900
2024-09-30PRPH2.350.110.00936
2024-10-01PRPH2.250.110.00936
2024-10-02PRPH2.360.110.00956
2024-10-03PRPH2.440.110.00994
2024-10-04PRPH2.470.110.00994
DateSymbolLastP/C OIP/C VolTotal OI
21 items Current Page1 of 1




21 items of 1

DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
2024-09-06PRPH2.75113.3- -0.61
2024-09-09PRPH2.77113.3- -0.61
2024-09-10PRPH2.76113.3- -0.61
2024-09-11PRPH2.69113.3- -0.61
2024-09-12PRPH2.54113.3- -0.61
2024-09-13PRPH2.47113.3- -0.61
2024-09-16PRPH2.45113.3- -0.61
2024-09-17PRPH2.63113.3- -0.61
2024-09-18PRPH2.45113.3- -0.61
2024-09-19PRPH2.45113.3- -0.61
2024-09-20PRPH2.35113.3- -0.61
2024-09-23PRPH2.40113.3- -0.61
2024-09-24PRPH2.22113.3- -0.61
2024-09-25PRPH2.12113.3- -0.61
2024-09-26PRPH2.27113.3- -0.61
2024-09-27PRPH2.40113.3- -0.61
2024-09-30PRPH2.41113.3- -0.61
2024-10-01PRPH2.22113.3- -0.61
2024-10-02PRPH2.41113.3- -0.61
2024-10-03PRPH2.40113.3- -0.61
2024-10-04PRPH2.39113.3- -0.61
DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
21 items Current Page1 of 1




21 items of 1

DateTickerInsider TransactionsInstitutional TransactionsFloat Short
2024-09-06PRPH0.0028.091.75
2024-09-09PRPH0.0029.551.75
2024-09-10PRPH0.0029.551.75
2024-09-11PRPH0.0029.551.75
2024-09-12PRPH0.0029.551.58
2024-09-13PRPH0.0029.551.58
2024-09-16PRPH0.0028.091.58
2024-09-17PRPH0.0028.091.58
2024-09-18PRPH0.0028.091.58
2024-09-19PRPH0.0028.091.58
2024-09-20PRPH0.0028.091.58
2024-09-23PRPH0.0028.091.58
2024-09-24PRPH0.0028.091.58
2024-09-25PRPH0.0028.091.63
2024-09-26PRPH0.0028.091.63
2024-09-27PRPH0.0028.091.63
2024-09-30PRPH0.0028.091.63
2024-10-01PRPH0.0028.091.63
2024-10-02PRPH0.0028.091.63
2024-10-03PRPH0.0028.091.63
2024-10-04PRPH0.0028.091.63
DateTickerInsider TransactionsInstitutional TransactionsFloat Short
21 items Current Page1 of 1

Last Quarter Act. EPS

-0.33

Avg. EPS Est. Current Quarter

0.04

Avg. EPS Est. Next Quarter

0.09

Insider Transactions

Institutional Transactions

28.09

Beta

-0.11

Average Sales Estimate Current Quarter

23

Average Sales Estimate Next Quarter

29

Fair Value (Academic)

Quality Score

23

Growth Score

38

Sentiment Score

93

Actual DrawDown %

85.1

Max Drawdown 5-Year %

-86.5

Target Price

16

P/E

Forward P/E

PEG

P/S

2.61

P/B

1.06

P/Free Cash Flow

EPS

-1.46

Average EPS Est. Cur. Y​

-0.61

EPS Next Y. (Est.)

0.48

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-146.39

Relative Volume

0.19

Return on Equity vs Sector %

-81.3

Return on Equity vs Industry %

-70.5

EPS 1 7Days Diff

EPS 1 30Days Diff

0.31

EBIT Estimation

ProPhase Labs, Inc.
Sector: Healthcare
Industry: Diagnostics & Research
Employees: 113
ProPhase Labs, Inc. develops and commercializes novel drugs, dietary supplements, and compounds in the United States. It operates through two segments: Diagnostic Services and Consumer Products. The company provides a range of TK supplements, including Legendz XL for male sexual health; and Triple Edge XL, an energy and stamina booster. It offers contract manufacturing services, such as product development, pre-commercialization, production, warehousing, and distribution; COVID-19 diagnostic information services to a range of customers, including health plans, third party payers, and government organizations; and respiratory pathogen panel molecular testing services, as well as personal genomics products and services. In addition, the company involved in the research, development, manufacture, distribution, marketing, and sale of over the counter (OTC) consumer healthcare products and dietary supplements; and retail operations. The company was formerly known as The Quigley Corporation. ProPhase Labs, Inc. was founded in 1989 and is headquartered in Garden City, New York.
stock quote shares PRPH – ProPhase Labs Inc Stock Price stock today
news today PRPH – ProPhase Labs Inc stock forecast ,stock prediction 2023 2024 2025
marketwatch PRPH – ProPhase Labs Inc yahoo finance google finance
stock history PRPH – ProPhase Labs Inc invest stock market
stock prices PRPH premarket after hours
ticker PRPH fair value insiders trading